-
Mid-Size Pharmaceuticals Market Analysis 2025 – Insights For Long-Term Investment & Planning
30 Jun 2025 10:28 GMT
… for blockbuster drugs, measures to contain healthcare costs, biotech breakthroughs, and … to elevated demand for medications. The application of mass … Ltd., BioMarin Pharmaceutical Inc., Mallinckrodt Plc, Exelixis Inc., Mylan Pharmaceuticals Inc., Neurocrine …
-
Pfizer: Reshma Parida to become new Senior Director - People Experience
03 Jul 2025 10:54 GMT
… positions at Teva Pharmaceuticals, Bristol Myers Squibb, and Mylan Pharmaceuticals.
Reshma Parida holds …
-
Global Hormone Replacement Therapy HRT Market Growth: Projected To Reach $37.9 Billion By 2029 With 8.6% CAGR
02 Jul 2025 13:21 GMT
… identical hormone formulations, sophisticated transdermal drug delivery systems, personalized hormone … ;S, Teva Pharmaceutical Industries Ltd., Mylan N.V., Bausch Health Companies Inc., … .com/report/drugs-for-hormonal-replacement-therapy-global …
-
Vertigo Treatment Market Expected To Grow at a CAGR of 5.23 % From 2025 to 2032
02 Jul 2025 09:28 GMT
… Mylan N.V. (United States)
Amneal Pharmaceuticals LLC (United States)
Prestige Consumer Healthtreatment … -Market/2066
Injectable Drug Delivery Market: https:… industries we cover include medical devices, pharmaceutical manufacturers, science and …
-
Major Gabapentin Market Trend 2025: Advancements Bioequivalent Gabapentin Tablets Boost Neurological Treatment Options
02 Jul 2025 09:18 GMT
… medicine, and a growing neurological disorder burden. Additionally, advancements in drug … . Pfizer Inc., Teva Pharmaceutical Industries Ltd., Mylan Inc., Apotex Inc., … International Inc., Accord Healthcare Limited, Strides Pharma Science Limited, and Ascend …
-
The Global Nocturnal Leg Cramps Treatment Market Report For M&A, Expansion, And Competitive Benchmarking (2025–2034)
01 Jul 2025 10:56 GMT
… function, improved drug delivery systems, a focus on holistic health, and … longer due to improved healthcare, nutrition, sanitation, and medical advancements, the demand … include Teva Pharmaceutical Industries Ltd., Mylan N.V., Astellas Pharma Inc., DAIICHI …
-
Global Multiple Sclerosis Treatment Market To Reach $31.55 Billion By 2029 With A Growth Rate Of 4.8%.
01 Jul 2025 10:56 GMT
… autoimmune disorders, expanding neurological healthcare infrastructure, and the rising … and Company, Teva Pharmaceutical Industries Ltd., Mylan N.V., Biogen … Antidepressants, Anticonvulsants, Bladder Dysfunction Drugs
4 By Monoclonal Antibodies: Natalizumab …
-
Protein Expression Market To Reach $5 Billion By 2032, Growing At A CAGR Of 7.6% From 2025, Says Meticulous Research®
30 Jun 2025 18:26 GMT
… and biotechnology research. As the healthcare industry faces increasing demand for personalized medicine … focus on pharma-academic collaborations for advanced protein research and drug discovery … such as Biocon Ltd. and Mylan N.V.'s biosimilar …
-
2024 H-1B petitions: Approvals for employers classified under Mining, Quarrying, and Oil and Gas Extraction industry across Southwest PA News publication area
30 Jun 2025 18:47 GMT
…
West Penn Allegheny Health System
Health Care and Social … .
Manufacturing
2
100%
0%
Mylan Pharmaceuticals, Inc.
Manufacturing
2
100% …
Centerville Clinics, Inc.
Health Care and Social Assistance
…
0%
Jefferson Regional Medical Center
Health Care and Social …
-
Global Invasive Ductal Carcinoma Therapeutics Market Forecast To Reach $12.55 Billion By 2029 With 8.6% Annual Growth
30 Jun 2025 13:28 GMT
… the incorporation of digital health platforms in patient management, … spread by using precision medicines, improving patient outcomes … Ingelheim, Mylan N.V., Daiichi Sankyo, Astellas Pharma Inc., Eisai … therapies, such as antibody-drug conjugates, to improve …
About
© 1995-2025